Storage of Calcium:
99% in bone/skeleton
1% intracellular
0.1% extracellular (predominantly bound to plasma proteins, mainly albumin)
Functions of Calcium:
Essential for blood clotting
Muscle contraction process
Bone growth and remodeling
Cell signaling, including neurotransmitter release (exocytosis)
Laboratory Measurement:
Methods include:
Spectrophotometric: e.g., metallochromic indicators (5-nitro-5'-methyl-BAPTA, o-cresolphthalein)
Ion-selective electrodes: for ionized calcium (blood gas instruments)
Reference range for adjusted calcium: 2.20-2.60 mmol/L
<2.20 mmol/L = hypocalcaemia
2.60 mmol/L = hypercalcaemia
Adjusted Calcium Calculation:
Formula: adjusted calcium = measured calcium + ((40 - albumin) x 0.02)
Distribution:
85% in bone, 14% in cells, 1% in blood
Functions of Phosphate:
Bone mineralization
Energy metabolism (ATP formation)
Nucleic acids synthesis
Acts as a buffer in urine
Signaling and enzyme cofactor
Laboratory Measurement:
Methods: Generally spectrophotometrically with ammonium molybdate indicator
Reference range: 0.8-1.5 mmol/L
Functions of Magnesium:
Enzyme cofactor for numerous reactions
Energy metabolism and ATP utilization
Membrane stabilization and neuromuscular excitability
Laboratory Measurement:
Spectrophotometric methods using indicators like Xylidyl blue
Reference range: 0.7-1.0 mmol/L
Major Regulators:
Parathyroid Hormone (PTH)
Vitamin D
Additional hormones:
PTH-related peptide (PTHrp)
Calcitonin
Fibroblast Growth Factor 23 (FGF23) affecting phosphate
Actions of PTH:
Increases calcium reabsorption in kidneys
Promotes bone resorption and release of calcium and phosphate
Activates vitamin D
Dependent on magnesium levels for secretion
Hypercalcemia:
Symptoms: bone pain, kidney stones, abdominal pain, psychological effects ("moans and groans")
Mechanisms: increased intestinal absorption, renal retention, and skeletal resorption
Hypocalcemia:
Symptoms: neuromuscular excitability, tetany, cardiac changes
Causes: vitamin D deficiency, hypoparathyroidism, renal failure
Hyperphosphatemia:
Linked to low calcium levels; chronic leads to tissue calcification
Diabetes ketoacidosis can cause acute effects due to acid-base disturbances
Hypophosphatemia:
Can be asymptomatic or lead to muscle weakness and respiratory failure
Commonly caused by redistribution into cells or bone, or renal/GI loss
Hypermagnesemia:
Very rare; results in ECG changes, respiratory issues
Hypomagnesemia:
Leads to arrhythmias, confusion, muscle weakness; commonly due to malnourishment or medications
Osteoporosis: Low bone mass and density
Rickets/Osteomalacia: Due to vitamin D or phosphate deficiency; diagnosed with DEXA scan
Paget’s Disease: Affects the bone remodeling process leading to weakness
Chronic Kidney Disease Mineral and Bone Disorders (CKD-MBD): Result from vitamin D activation issues, leading to complications in bone health
Indicative of bone health and metabolic activity
Formation markers: P1NP, ALP
Resorption markers: CTX
Useful for monitoring treatment but subject to variability
Further Reading: Clinical Utility of Bone Marker Measurements and other relevant literature for understanding the diagnostic implications of bone turnover markers.
Case 1: 52-year-old male with low adjusted calcium, high ALP (indicating primary hyperparathyroidism possibly due to vitamin D deficiency)
Case 2: 80-year-old male with signs pointing towards acute kidney injury related to electrolyte imbalance and metabolic derangements.